Not only using in-silico analysis, the expression levels of CDC20 in CCA cell lines as well as the investigation of the anti-tumor activity of novel potential targeted drugs against CCA cells were compared with the standard chemotherapy, gemcitabine. The gene discussed is CDC20; the disease is neoplasm.